Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Biallelic ELOC-Inactivated Renal Cell Carcinoma: Molecular Features Supporting Classification as a Distinct Entity

Modern Pathology(2023)10.1016/j.modpat.2023.100194Source: DataRank Database

Biallelic ELOC-Inactivated Renal Cell Carcinoma: Molecular Features Supporting Classification as a Distinct Entity is a research paper published in Modern Pathology (2023). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 3.79)OA: hybridTopics (28)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Dorothea Rutishauser ORCID,Bettina Sobottka ORCID,Peter Schraml ORCID,Niko Beerenwinkel ORCID,Holger Moch ORCID

Live enrichment

PubMed:37088333 OpenAlex:https://openalex.org/W4366779162

FWCI

3.79

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.modpat.2023.100194

HYBRIDhttps://doi.org/10.1016/j.modpat.2023.100194

publisherhttps://doi.org/10.1016/j.modpat.2023.100194

publisherhttps://api.elsevier.com/content/article/PII:S0893395223000996?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0893395223000996?httpAccept=text/plain

Fields of Study

Renal cell carcinoma treatmentRenal and related cancersTuberous Sclerosis Complex ResearchMedicine

MeSH Terms

ElonginCarcinoma, Renal CellHumansKidney NeoplasmsVascular Endothelial Growth Factor AVon Hippel-Lindau Tumor Suppressor ProteinTOR Serine-Threonine Kinases

Keywords

Cancer researchClear cellTuberous sclerosisTSC1TSC2BiologyClear cell renal cell carcinomaRenal cell carcinomaPapillary renal cell carcinomasPathologyPI3K/AKT/mTOR pathwayMolecular biologyGeneticsMedicineTranslational ResearchVhl GeneTumor Classification

Sustainable Development Goals

SDG 0: Good health and well-being